Article

Dr. Haller honored

Ophthalmology Times Editorial Advisory Board member Julia A. Haller, MD, was formally named the first holder of the William Tasman, MD, Endowed Chair in Ophthalmology at the Wills Eye Institute on Sept. 8.

Philadelphia-Ophthalmology Times Editorial Advisory Board member Julia A. Haller, MD, was formally named the first holder of the William Tasman, MD, Endowed Chair in Ophthalmology at the Wills Eye Institute on Sept. 8.

The honor is named for the renowned retina surgeon who was ophthalmologist-in-chief at Wills for 22 years. Dr. Haller has held that title at the Institute since November 2007. She also is professor and chairwoman of the department of ophthalmology at Thomas Jefferson University and one of two directors of the Wills Vision Research Center at Jefferson.

Dr. Haller has published more than 250 papers in the peer-reviewed literature as well as 20 book chapters. She was president of the American Society of Retina Specialists from 2006 to 2008.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.